Mason Street Advisors, LLC Coherus Bio Sciences, Inc. Transaction History

Mason Street Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$14.42 - $21.39 $340,932 - $505,723	-23,643 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$16.56 - $18.94 $778 - $890	47 Added 0.2%	23,643 $411,000
Q3 2020 Nov 13, 2020	BUY	$17.41 - $19.89 $12,187 - $13,923	700 Added 3.06%	23,596 $433,000
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $330,389 - $438,687	22,896 New	22,896 $409,000

140

75.9M

79.1K

100K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $58.3M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.